NovaBridge Biosciences Deferred Tax Liabilities, Gross
NovaBridge Biosciences (NBP) had Deferred Tax Liabilities, Gross of $664.00 thousand as of 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-04-07
- 2023-12-31: Deferred Tax Liabilities, Gross 17.72M CNY.
- 2022-12-31: Deferred Tax Liabilities, Gross 17.83M CNY.
- 2021-12-31: Deferred Tax Liabilities, Gross 17.95M CNY.
- 2020-12-31: Deferred Tax Liabilities, Gross 48.13M CNY.
CNY
| Period end | Deferred Tax Liabilities, Gross |
|---|---|
| 2023-12-31 | 17.72M CNY 20-F · filed 2024-04-30 |
| 2022-12-31 | 17.83M CNY 20-F · filed 2024-04-30 |
| 2021-12-31 | 17.95M CNY 20-F · filed 2023-05-01 |
| 2020-12-31 | 48.13M CNY 20-F · filed 2022-04-29 |
| 2019-12-31 | 37.21M CNY 20-F · filed 2021-04-28 |
| 2018-12-31 | 37.21M CNY 20-F · filed 2021-04-28 |
| 2017-12-31 | 37.21M CNY 20-F · filed 2020-04-29 |
USD
| Period end | Deferred Tax Liabilities, Gross | Deferred Tax Liabilities, Gross as first filed |
|---|---|---|
| 2025-12-31 | $664.00K 20-F · filed 2026-04-07 | |
| 2024-12-31 | $844.00K 20-F · filed 2026-04-07 | |
| 2023-12-31 | $0.00 20-F · filed 2025-04-03 | $2.50M 20-F · filed 2024-04-30 |
| 2022-12-31 | $2.58M 20-F · filed 2023-05-01 | |
| 2021-12-31 | $2.82M 20-F · filed 2022-04-29 | |
| 2020-12-31 | $7.38M 20-F · filed 2021-04-28 | |
| 2019-12-31 | $5.34M 20-F · filed 2020-04-29 |